Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Lab Invest ; 97(11): 1385-1396, 2017 11.
Article in English | MEDLINE | ID: mdl-28892096

ABSTRACT

Primary sclerosing cholangitis (PSC) is an incurable, fibroinflammatory biliary disease for which there is no effective pharmacotherapy. We recently reported cholangiocyte senescence as an important phenotype in PSC while others showed that portal macrophages accumulate in PSC. Unfortunately, our ability to explore cholangiocyte senescence and macrophage accumulation has been hampered by limited in vitro models. Thus, our aim was to develop and characterize a three-dimensional (3D) model of normal and diseased bile ducts (cholangioids) starting with normal human cholangiocytes (NHC), senescent NHC (NHC-sen), and cholangiocytes from PSC patients. In 3D culture, NHCs formed spheroids of ~5000 cells with a central lumen of ~150 µm. By confocal microscopy and western blot, cholangioids retained expression of cholangiocyte proteins (cytokeratin 7/19) and markers of epithelial polarity (secretin receptor and GM130). Cholangioids are functionally active, and upon secretin stimulation, luminal size increased by ~80%. Cholangioids exposed to hydrogen peroxide exhibited cellular senescence and the senescence-associated secretory phenotype (SASP; increased IL-6, p21, SA-ß-Gal, yH2A.x and p16 expression). Furthermore, cholangioids derived from NHC-sen or PSC patients were smaller and had slower growth than the controls. When co-cultured with THP-1 macrophages, the number of macrophages associated with NHC-sen or PSC cholangioids was five- to seven-fold greater compared to co-culture with non-senescent NHC. We observed that NHC-sen and PSC cholangioids release greater number of extracellular vesicles (EVs) compared to controls. Moreover, conditioned media from NHC-sen cholangioids resulted in an ~2-fold increase in macrophage migration. In summary, we developed a method to generate normal and diseased cholangioids, characterized them morphologically and functionally, showed that they can be induced to senescence and SASP, and demonstrated both EV release and macrophage attraction. This novel model mimics several features of PSC, and thus will be useful for studying the pathogenesis of PSC and potentially identifying new therapeutic targets.


Subject(s)
Bile Ducts/pathology , Cholangitis, Sclerosing/pathology , Spheroids, Cellular/pathology , Autoantigens/metabolism , Bile Ducts/drug effects , Bile Ducts/metabolism , Bile Ducts/ultrastructure , Biomarkers/metabolism , Cell Line , Cells, Cultured , Cellular Senescence/drug effects , Cholangitis, Sclerosing/immunology , Cholangitis, Sclerosing/metabolism , Coculture Techniques , Culture Media, Conditioned , Extracellular Vesicles/drug effects , Extracellular Vesicles/metabolism , Extracellular Vesicles/pathology , Extracellular Vesicles/ultrastructure , Gene Expression Regulation/drug effects , Humans , Hydrogen Peroxide/toxicity , Keratin-19/metabolism , Keratin-7/metabolism , Macrophage Activation , Macrophages/cytology , Macrophages/immunology , Membrane Proteins/metabolism , Microscopy, Electron, Transmission , Multivesicular Bodies/drug effects , Multivesicular Bodies/metabolism , Multivesicular Bodies/pathology , Multivesicular Bodies/ultrastructure , Oxidants/toxicity , Receptors, G-Protein-Coupled/metabolism , Receptors, Gastrointestinal Hormone/metabolism , Spheroids, Cellular/drug effects , Spheroids, Cellular/metabolism , Spheroids, Cellular/ultrastructure
2.
J Clin Med ; 4(9): 1688-712, 2015 Aug 26.
Article in English | MEDLINE | ID: mdl-26343736

ABSTRACT

The cholangiopathies are a group of liver diseases resulting from different etiologies but with the cholangiocyte as the primary target. As a group, the cholangiopathies result in significant morbidity and mortality and represent one of the main indications for liver transplant in both children and adults. Contributing to this situation is the absence of a thorough understanding of their pathogenesis and a lack of adequate diagnostic and prognostic biomarkers. MicroRNAs are small non-coding RNAs that modify gene expression post-transcriptionally. They have been implicated in the pathogenesis of many diseases, including the cholangiopathies. Thus, in this review we provide an overview of the literature on miRNAs in the cholangiopathies and discuss future research directions.

3.
Semin Liver Dis ; 35(1): 26-35, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25632932

ABSTRACT

Cholangiocytes, the epithelial cells lining the biliary tree, represent only a small portion of the total liver cell population (3-5%), but they are responsible for the secretion of up to 40% of total daily bile volume. In addition, cholangiocytes are the target of a diverse group of liver diseases affecting the biliary tract, the cholangiopathies; for most of these conditions, the pathological mechanisms are unclear. MicroRNAs (miRNAs) are small, noncoding RNAs that posttranscriptionally regulate gene expression. Thus, it is not surprising that altered miRNA profiles underlie the dysregulation of several proteins involved in the pathobiology of the cholangiopathies, as well as showing promise as diagnostic and prognostic tools. Here the authors review recent work relevant to the role of miRNAs in the etiopathogenesis of several of the cholangiopathies (i.e., fibroinflammatory cholangiopathies and polycystic liver diseases), discuss their value as prognostic and diagnostic tools, and provide suggestions for further research.


Subject(s)
Biliary Tract Diseases/genetics , Epithelial Cells/metabolism , MicroRNAs/genetics , Bile Duct Neoplasms/genetics , Bile Duct Neoplasms/metabolism , Bile Ducts, Intrahepatic , Biliary Atresia/genetics , Biliary Atresia/metabolism , Biliary Tract/cytology , Biliary Tract Diseases/metabolism , Cholangiocarcinoma/genetics , Cholangiocarcinoma/metabolism , Cholangitis, Sclerosing/genetics , Cholangitis, Sclerosing/metabolism , Epithelial Cells/cytology , Humans , Liver Cirrhosis, Biliary/genetics , Liver Cirrhosis, Biliary/metabolism , MicroRNAs/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...